Literature DB >> 33492952

Mechanistic Basis of OXA-48-like β-Lactamases' Hydrolysis of Carbapenems.

Vlatko Stojanoski, Liya Hu, Banumathi Sankaran1, Feng Wang2, Peng Tao2, B V Venkataram Prasad, Timothy Palzkill.   

Abstract

Carbapenem-hydrolyzing class D β-lactamases (CHDLs) are an important source of resistance to these last resort β-lactam antibiotics. OXA-48 is a member of a group of CHDLs named OXA-48-like enzymes. On the basis of sequence similarity, OXA-163 can be classified as an OXA-48-like enzyme, but it has altered substrate specificity. Compared to OXA-48, it shows impaired activity for carbapenems but displays an enhanced hydrolysis of oxyimino-cephalosporins. Here, we address the mechanistic and structural basis for carbapenem hydrolysis by OXA-48-like enzymes. Pre-steady-state kinetic analysis indicates that the rate-limiting step for OXA-48 and OXA-163 hydrolysis of carbapenems is deacylation and that the greatly reduced carbapenemase activity of OXA-163 compared to that of OXA-48 is due entirely to a slower deacylation reaction. Furthermore, our structural data indicate that the positioning of the β5-β6 loop is necessary for carbapenem hydrolysis by OXA-48. A major difference between the OXA-48 and OXA-163 complexes with carbapenems is that the 214-RIEP-217 deletion in OXA-163 creates a large opening in the active site that is absent in the OXA-48/carbapenem structures. We propose that the larger active site results in less constraint on the conformation of the 6α-hydroxyethyl group in the acyl-enzyme. The acyl-enzyme intermediate assumes multiple conformations, most of which are incompatible with rapid deacylation. Consistent with this hypothesis, molecular dynamics simulations indicate that the most stable complex is formed between OXA-48 and imipenem, which correlates with the OXA-48 hydrolysis of imipenem being the fastest observed. Furthermore, the OXA-163 complexes with imipenem and meropenem are the least stable and show significant conformational fluctuations, which correlates with the slow hydrolysis of these substrates.

Entities:  

Keywords:  OXA-48-like enzymes; OXA-enzymes; antibiotic resistance; carbapenemases; carbapenems; serine β-lactamases

Mesh:

Substances:

Year:  2021        PMID: 33492952      PMCID: PMC8571991          DOI: 10.1021/acsinfecdis.0c00798

Source DB:  PubMed          Journal:  ACS Infect Dis        ISSN: 2373-8227            Impact factor:   5.084


  67 in total

Review 1.  CHARMM: the biomolecular simulation program.

Authors:  B R Brooks; C L Brooks; A D Mackerell; L Nilsson; R J Petrella; B Roux; Y Won; G Archontis; C Bartels; S Boresch; A Caflisch; L Caves; Q Cui; A R Dinner; M Feig; S Fischer; J Gao; M Hodoscek; W Im; K Kuczera; T Lazaridis; J Ma; V Ovchinnikov; E Paci; R W Pastor; C B Post; J Z Pu; M Schaefer; B Tidor; R M Venable; H L Woodcock; X Wu; W Yang; D M York; M Karplus
Journal:  J Comput Chem       Date:  2009-07-30       Impact factor: 3.376

Review 2.  Mechanisms of β-lactam antimicrobial resistance and epidemiology of major community- and healthcare-associated multidrug-resistant bacteria.

Authors:  Sarah S Tang; Anucha Apisarnthanarak; Li Yang Hsu
Journal:  Adv Drug Deliv Rev       Date:  2014-08-16       Impact factor: 15.470

3.  The structure of beta-lactamases.

Authors:  R P Ambler
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1980-05-16       Impact factor: 6.237

4.  Role of Arginine 214 in the Substrate Specificity of OXA-48.

Authors:  Saoussen Oueslati; Pascal Retailleau; Ludovic Marchini; Camille Berthault; Laurent Dortet; Rémy A Bonnin; Bogdan I Iorga; Thierry Naas
Journal:  Antimicrob Agents Chemother       Date:  2020-04-21       Impact factor: 5.191

5.  Critical involvement of a carbamylated lysine in catalytic function of class D beta-lactamases.

Authors:  D Golemi; L Maveyraud; S Vakulenko; J P Samama; S Mobashery
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-27       Impact factor: 11.205

6.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

7.  Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone φ, ψ and side-chain χ(1) and χ(2) dihedral angles.

Authors:  Robert B Best; Xiao Zhu; Jihyun Shim; Pedro E M Lopes; Jeetain Mittal; Michael Feig; Alexander D Mackerell
Journal:  J Chem Theory Comput       Date:  2012-07-18       Impact factor: 6.006

8.  Substrate Specificity of OXA-48 after β5-β6 Loop Replacement.

Authors:  Laura Dabos; Agustin Zavala; Rémy A Bonnin; Oliver Beckstein; Pascal Retailleau; Bogdan I Iorga; Thierry Naas
Journal:  ACS Infect Dis       Date:  2020-03-19       Impact factor: 5.084

9.  Carbapenems and SHV-1 beta-lactamase form different acyl-enzyme populations in crystals and solution.

Authors:  Matthew Kalp; Paul R Carey
Journal:  Biochemistry       Date:  2008-10-16       Impact factor: 3.162

10.  Overview of the CCP4 suite and current developments.

Authors:  Martyn D Winn; Charles C Ballard; Kevin D Cowtan; Eleanor J Dodson; Paul Emsley; Phil R Evans; Ronan M Keegan; Eugene B Krissinel; Andrew G W Leslie; Airlie McCoy; Stuart J McNicholas; Garib N Murshudov; Navraj S Pannu; Elizabeth A Potterton; Harold R Powell; Randy J Read; Alexei Vagin; Keith S Wilson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-03-18
View more
  8 in total

1.  Multiscale Simulations Identify Origins of Differential Carbapenem Hydrolysis by the OXA-48 β-Lactamase.

Authors:  Viivi H A Hirvonen; Tal Moshe Weizmann; Adrian J Mulholland; James Spencer; Marc W van der Kamp
Journal:  ACS Catal       Date:  2022-04-04       Impact factor: 13.700

2.  C6 Hydroxymethyl-Substituted Carbapenem MA-1-206 Inhibits the Major Acinetobacter baumannii Carbapenemase OXA-23 by Impeding Deacylation.

Authors:  Nichole K Stewart; Marta Toth; Maha A Alqurafi; Weirui Chai; Thu Q Nguyen; Pojun Quan; Mijoon Lee; John D Buynak; Clyde A Smith; Sergei B Vakulenko
Journal:  mBio       Date:  2022-04-14       Impact factor: 7.786

3.  Docking and Molecular Dynamic of Microalgae Compounds as Potential Inhibitors of Beta-Lactamase.

Authors:  Roberto Pestana-Nobles; Yani Aranguren-Díaz; Elwi Machado-Sierra; Juvenal Yosa; Nataly J Galan-Freyle; Laura X Sepulveda-Montaño; Daniel G Kuroda; Leonardo C Pacheco-Londoño
Journal:  Int J Mol Sci       Date:  2022-01-31       Impact factor: 5.923

4.  Structural and Functional Characterization of OXA-48: Insight into Mechanism and Structural Basis of Substrate Recognition and Specificity.

Authors:  Jiachi Chiou; Qipeng Cheng; Perry Tim-Fat Shum; Marcus Ho-Yin Wong; Edward Wai-Chi Chan; Sheng Chen
Journal:  Int J Mol Sci       Date:  2021-10-25       Impact factor: 5.923

5.  Comparison of the Performance of Phenotypic Methods for the Detection of Carbapenem-Resistant Enterobacteriaceae (CRE) in Clinical Practice.

Authors:  Zhijie Zhang; Dayan Wang; Yahui Li; Yong Liu; Xiaosong Qin
Journal:  Front Cell Infect Microbiol       Date:  2022-02-21       Impact factor: 5.293

6.  Dynamic Gene Clusters Mediating Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates.

Authors:  Samy Selim; Osama Ahmed Faried; Mohamed S Almuhayawi; Osama A Mohammed; Fayez M Saleh; Mona Warrad
Journal:  Antibiotics (Basel)       Date:  2022-01-28

7.  Evolution of β-lactamase-mediated cefiderocol resistance.

Authors:  Christopher Fröhlich; Vidar Sørum; Nobuhiko Tokuriki; Pål Jarle Johnsen; Ørjan Samuelsen
Journal:  J Antimicrob Chemother       Date:  2022-08-25       Impact factor: 5.758

8.  Incidence of Vancomycin-Resistant Staphylococcus aureus Strains among Patients with Urinary Tract Infections.

Authors:  Samy Selim; Osama Ahmed Faried; Mohammed S Almuhayawi; Fayez M Saleh; Mohamed Sharaf; Nihal El Nahhas; Mona Warrad
Journal:  Antibiotics (Basel)       Date:  2022-03-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.